Skip to main content
Log in

Luciferase expression is driven by the promoter of fibroblast activation protein-α in murine pulmonary fibrosis

  • Original Research Paper
  • Published:
Biotechnology Letters Aims and scope Submit manuscript

Abstract

Objectives

We used optical imaging of live animals and transgenic technology to develop a pulmonary fibrosis model in mice that can non-invasively and in real-time trace the pulmonary fibrosis process.

Results

Fibroblast activation protein-α (FAPα) is selectively expressed in fibrotic foci of human pulmonary fibrosis. It is not expressed in normal tissue. We confirmed that FAPα is upregulated in fibroblasts of murine pulmonary fibrosis. Moreover, TGF-β1, a central pathological mediator of fibrotic diseases, could promote FAPα expression in mouse embryonic fibroblasts. Luciferase reporter assays showed that 5.4 kb FAPα promoter response activities to TGF-β1 was stronger than of the 2.1 kb promoter. We generated a transgenic mouse line expressing firefly luciferase under the control of the 5.4 kb FAPα gene promoter (FAPα-p-luc). After experimentally inducing murine pulmonary fibrosis, there luminescence appeared in the chests and excised lungs of FAPα-p-luc mice. The intensity of luminescence became stronger with the exacerbation of pulmonary fibrosis.

Conclusion

Fluorescence intensity reflects the degree of pulmonary fibrosis in FAPα-p-luc mice. and this mouse model may be used to investigate molecular mechanisms and drug screening of pulmonary fibrosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

BLI:

Bioluminescence imaging

BLM:

Bleomycin

ECM:

Extracellular matrix

EGR1:

Early growth response 1

FAPα:

Fibroblast activation protein-α

IPF:

Idiopathic pulmonary fibrosis

Luc:

Luciferase

MEFs:

Mouse embryonic fibroblasts

IPF:

Idiopathic pulmonary fibrosis

TGF-β1:

Transforming growth factor-β1

Tg:

Transgenic

References

  • Acharya PS, Zukas A, Chandan V, Katzenstein AL, Pure E (2006) Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis. Hum Pathol 37:352–360

    Article  CAS  PubMed  Google Scholar 

  • Badr CE (2014) Bioluminescence imaging: basics and practical limitations. Methods Mol Biol 1098:1–18

    Article  CAS  PubMed  Google Scholar 

  • Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G (1993) Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 122:103–111

    Article  CAS  PubMed  Google Scholar 

  • Jacob M, Chang L, Pure E (2012) Fibroblast activation protein in remodeling tissues. Curr Mol Med 12:1220–1243

    Article  CAS  PubMed  Google Scholar 

  • Leilei Y, Bing L, Yang L, Shaoxia W, Yuan X, Dongping W, Huahu Y, Shichen S, Guangzhou Z, Ruiyun P, Lin Z, Wenlong L (2014) iRhom2 mutation leads to aberrant hair follicle differentiation in mice. PLoS ONE 9:e115114

    Article  PubMed Central  PubMed  Google Scholar 

  • Levy MT, McCaughan GW, Marinos G, Gorrell MD (2002) Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection. Liver 22:93–101

    Article  CAS  PubMed  Google Scholar 

  • Liu B, Xu Y, Li WL, Zeng L (2015) Proteomic analysis of differentially expressed skin proteins in iRhom2(Uncv) mice. BMB Rep 48:19–24

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Martinez FJ, Safrin S, Weycker D, Starko KM, Bradford WZ, King TE Jr, Flaherty KR, Schwartz DA, Noble PW, Raghu G, Brown KK (2005) The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med 142:963–967

    Article  PubMed  Google Scholar 

  • Moeller A, Ask K, Warburton D, Gauldie J, Kolb M (2008) The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol 40:362–382

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Mouratis MA, Aidinis V (2011) Modeling pulmonary fibrosis with bleomycin. Curr Opin Pulm Med 17:355–361

    Article  CAS  PubMed  Google Scholar 

  • Noble PW, Homer RJ (2005) Back to the future: historical perspective on the pathogenesis of idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 33:113–120

    Article  CAS  PubMed  Google Scholar 

  • Rettig WJ, Su SL, Fortunato SR, Scanlan MJ, Raj BK, Garin-Chesa P, Healey JH, Old LJ (1994) Fibroblast activation protein: purification, epitope mapping and induction by growth factors. Int J Cancer 58:385–392

    Article  CAS  PubMed  Google Scholar 

  • Scanlan MJ, Raj BK, Calvo B, Garin-Chesa P, Sanz-Moncasi MP, Healey JH, Old LJ, Rettig WJ (1994) Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. Proc Natl Acad Sci USA 91:5657–5661

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Wang Y, Sun Z, Peng J, Zhan L (2007) Bioluminescent imaging of hepatocellular carcinoma in live mice. Biotechnol Lett 29:1665–1670

    Article  CAS  PubMed  Google Scholar 

  • Wolters PJ, Collard HR, Jones KD (2014) Pathogenesis of idiopathic pulmonary fibrosis. Annu Rev Pathol 9:157–179

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Yang L, Wang L, Yang X (2009) Disruption of Smad4 in mouse epidermis leads to depletion of follicle stem cells. Mol Biol Cell 20:882–890

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Zhang J, Valianou M, Cheng JD (2010) Identification and characterization of the promoter of fibroblast activation protein. Front Biosci (Elite Ed) 2:1154–1163

    Article  PubMed Central  Google Scholar 

Download references

Acknowledgments

We thank Dr. Tao Zhou, Ms Weili Gong for performing in vivo BLI, Dr. Xing Huang for careful review of the manuscript. We would like to thank staff of the Institute of JingFeng Medical Laboratory Animal for animal husbandry. This work was supported by the National Natural Science Foundation of China (31101679).

Conflict of interest

The authors state no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Li Wenlong.

Additional information

Li Wenlong and Yang Leilei have contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wenlong, L., Leilei, Y., Wei, F. et al. Luciferase expression is driven by the promoter of fibroblast activation protein-α in murine pulmonary fibrosis. Biotechnol Lett 37, 1757–1763 (2015). https://doi.org/10.1007/s10529-015-1855-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10529-015-1855-8

Keywords

Navigation